Processa Pharmaceuticals, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Processa Pharmaceuticals, Inc. (PCSA) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$492.43 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-14.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-14
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$492.43K.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$683.26K, a 137.75% decline year-over-year.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$426.23K, a 232.25% decline year-over-year.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $1.07M.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$1.11M, a 162.32% decline from fiscal 2017.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $1.78M, a 65.64% increase from fiscal 2016.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $1.07M.
- Processa Pharmaceuticals, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$10.60K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 27 month | Cash and Cash Equivalents, Period Increase (Decrease) 30 month | Cash and Cash Equivalents, Period Increase (Decrease) 33 month | Cash and Cash Equivalents, Period Increase (Decrease) 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$492.43K 10-Q · filed 2019-05-14 | -$1.18M derived: sum of 2 quarters · filed 2019-05-14 | -$1.60M derived: sum of 3 quarters · filed 2019-05-14 | -$528.11K derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2018-12-31 | -$683.26K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | -$1.11M derived: sum of 2 quarters · filed 2019-04-08 | -$35.68K derived: sum of 3 quarters · filed 2019-04-08 | -$1.11M 10-K/A · filed 2019-04-08 | ||||||||
| 2018-09-30 | -$426.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $647.58K derived: sum of 2 quarters · filed 2018-11-14 | -$423.21K 10-Q · filed 2018-11-14 | $1.39M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2018-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $3.02K 10-Q · filed 2018-08-14 | $1.81M derived: sum of 3 quarters · filed 2019-05-14 | $2.14M derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2018-03-31 | -$1.07M 10-Q · filed 2019-05-14 | $739.27K derived: sum of 2 quarters · filed 2019-05-14 | $1.06M derived: sum of 3 quarters · filed 2019-05-14 | $764.33K derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2017-12-31 | $1.81M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $2.13M derived: sum of 2 quarters · filed 2019-04-08 | $1.84M derived: sum of 3 quarters · filed 2019-04-08 | $1.78M 10-K/A · filed 2019-04-08 | ||||||||
| 2017-09-30 | $322.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $25.05K derived: sum of 2 quarters · filed 2018-11-14 | -$34.53K 10-Q · filed 2018-11-14 | $77.03K 10-Q · filed 2017-11-20 | $1.04M derived: sum of 4 quarters · filed 2018-11-14 | |||||||
| 2017-06-30 | -$297.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$356.81K 10-Q · filed 2018-08-14 | -$1.29K 10-Q · filed 2017-10-04 | $719.29K derived: sum of 3 quarters · filed 2018-08-14 | $711.03K derived: sum of 4 quarters · filed 2018-08-14 | |||||||
| 2017-03-31 | -$59.58K 10-Q · filed 2018-05-21 | -$1.60K 10-Q · filed 2017-10-04 | $1.02M derived: sum of 2 quarters · filed 2018-05-21 | $1.01M derived: sum of 3 quarters · filed 2018-05-21 | $1.02M derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | $1.07M derived: sum of 2 quarters · filed 2018-04-16 | $1.08M derived: sum of 3 quarters · filed 2018-04-16 | $1.07M 10-K · filed 2018-04-16 | -$11.20K 10-K · filed 2017-09-25 | |||||||
| 2016-09-30 | -$8.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $4.16K derived: sum of 2 quarters · filed 2017-11-20 | -$4.21K 10-Q · filed 2017-11-20 | -$8.67K derived: sum of 4 quarters · filed 2017-11-20 | ||||||||
| 2016-06-30 | $12.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $4.06K 10-Q · filed 2017-10-04 | -$409.00 derived: sum of 3 quarters · filed 2017-10-04 | -$505.00 derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2016-03-31 | -$8.37K 10-Q · filed 2017-10-04 | -$12.84K derived: sum of 2 quarters · filed 2017-10-04 | -$12.93K derived: sum of 3 quarters · filed 2017-10-04 | -$39.52K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2015-12-31 | -$4.47K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$4.56K derived: sum of 2 quarters · filed 2017-09-25 | -$31.15K derived: sum of 3 quarters · filed 2017-09-25 | -$10.60K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | -$96.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$26.69K derived: sum of 2 quarters · filed 2017-09-08 | -$6.14K 10-Q · filed 2017-09-08 | -$36.83K derived: sum of 4 quarters · filed 2017-09-08 | ||||||||
| 2015-06-30 | -$26.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$6.04K 10-Q · filed 2017-08-30 | -$36.73K derived: sum of 3 quarters · filed 2017-08-30 | -$20.90K derived: sum of 4 quarters · filed 2017-08-30 | ||||||||
| 2015-03-31 | $20.55K 10-Q · filed 2017-08-07 | -$10.14K derived: sum of 2 quarters · filed 2017-08-07 | $5.69K derived: sum of 3 quarters · filed 2017-08-07 | -$36.66K derived: sum of 4 quarters · filed 2017-08-07 | ||||||||
| 2014-12-31 | -$30.69K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$14.86K derived: sum of 2 quarters · filed 2017-06-19 | -$57.20K derived: sum of 3 quarters · filed 2017-06-19 | -$161.82K 10-K · filed 2017-06-19 | -$165.63K 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | $15.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | -$26.51K derived: sum of 2 quarters · filed 2015-12-01 | -$131.13K 10-Q · filed 2015-12-01 | -$940.20K derived: sum of 4 quarters · filed 2015-12-01 | ||||||||
| 2014-06-30 | -$42.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$146.97K 10-Q · filed 2015-08-19 | -$956.04K derived: sum of 3 quarters · filed 2015-08-19 | -$583.90K derived: sum of 4 quarters · filed 2015-08-19 | ||||||||
| 2014-03-31 | -$104.62K 10-Q · filed 2015-05-15 | -$913.69K derived: sum of 2 quarters · filed 2015-05-15 | -$541.56K derived: sum of 3 quarters · filed 2015-05-15 | -$333.24K derived: sum of 4 quarters · filed 2015-05-15 | $82.25K 10-Q · filed 2014-05-14 | |||||||
| 2013-12-31 | -$809.07K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | -$436.94K derived: sum of 2 quarters · filed 2015-04-14 | -$228.63K derived: sum of 3 quarters · filed 2015-04-14 | -$834.61K 10-K · filed 2015-04-14 | $186.86K 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $372.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $580.45K derived: sum of 2 quarters · filed 2014-11-13 | -$25.54K 10-Q · filed 2014-11-13 | -$396.38K derived: sum of 4 quarters · filed 2014-11-13 | $1.00M 10-Q · filed 2013-11-08 | |||||||
| 2013-06-30 | $208.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | -$397.67K 10-Q · filed 2014-08-19 | -$768.51K derived: sum of 3 quarters · filed 2014-08-19 | -$1.51M derived: sum of 4 quarters · filed 2014-08-19 | $629.80K 10-Q/A · filed 2013-09-06 | |||||||
| 2013-03-31 | -$605.99K 10-Q · filed 2014-05-14 | -$976.82K derived: sum of 2 quarters · filed 2014-05-14 | -$1.72M derived: sum of 3 quarters · filed 2014-05-14 | |||||||||
| 2012-12-31 | -$370.84K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$1.11M derived: sum of 2 quarters · filed 2014-03-27 | -$1.77M 10-K · filed 2014-03-27 | |||||||||
| 2012-09-30 | -$738.51K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$1.40M 10-Q · filed 2013-11-08 | ||||||||||
| 2012-06-30 | -$664.11K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |